TPG Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
1,791
+156
+10% +$36.4K 0.25% 70
2026
Q1
$400K Buy
1,635
+3
+0.2% +$699 0.25% 67
2025
Q4
$338K Buy
1,632
+4
+0.2% +$791 0.21% 75
2025
Q3
$302K Buy
1,628
+55
+3% +$9.42K 0.2% 78
2025
Q2
$240K Buy
1,573
+5
+0.3% +$769 0.17% 88
2025
Q1
$260K Sell
1,568
-60
-4% -$9.39K 0.21% 72
2024
Q4
$235K Buy
1,628
+5
+0.3% +$775 0.18% 75
2024
Q3
$263K Sell
1,623
-60
-4% -$9.56K 0.21% 77
2024
Q2
$246K Buy
+1,683
New +$250K 0.21% 73

Other funds holding JNJ

TPG Advisors's JNJ Position: Q2 2026 in Review

TPG Advisors increased its Johnson & Johnson (JNJ) stake by 9.5% in Q2 2026, buying an estimated $36.4K and bringing the position to 1,791 shares worth $455K. The position accounts for 0.25% of the portfolio, ranked #70.

TPG Advisors first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • TPG Advisors held 1,791 shares of Johnson & Johnson worth $455K as of Q2 2026.
  • TPG Advisors bought 156 Johnson & Johnson shares in Q2 2026, an estimated $36.4K.
  • Johnson & Johnson made up 0.25% of TPG Advisors's portfolio in Q2 2026, its #70 holding.
  • TPG Advisors first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on TPG Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.